Wordt geladen...

Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myeloma

Multiple Myeloma (MM) is a haematologic malignancy characterized by the accumulation of clonal plasma cells in the bone marrow. Over the last 10–15 y the introduction of the proteasome-inhibitor bortezomib has improved MM prognosis, however relapse due to bortezomib-resistance is inevitable and the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cell Cycle
Hoofdauteurs: Murray, Megan Y, Zaitseva, Lyubov, Auger, Martin J, Craig, Jenny IO, MacEwan, David J, Rushworth, Stuart A, Bowles, Kristian M
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2015
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613153/
https://ncbi.nlm.nih.gov/pubmed/25565020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2014.998067
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!